A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects

A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects.

The purpose of this study is to evaluate the safety and efficacy of the iStent trabecular micro-bypass stent in reducing intraocular pressure (IOP) in refractory open-angle glaucoma subjects.

Glaukos Corporation conducted a clinical research study at multiple (approximately 7) investigational sites within Europe.

Inclusion Criteria:

• Diagnosed with primary open-angle glaucoma (POAG)
• Subject on maximally tolerated medical therapy or where noncompliance with medication has been document
• Subject has failed a conventional glaucoma surgical procedure. (trabeculectomy, Trabeculoplasty(ALT), viscocanalostomy, collagen implant)

Exclusion Criteria:

• Angle closure glaucoma
• Fellow eye already enrolled